Table 2 HR of OS between male and female patients with stage 4 gastric adenocarcinoma from TCGA dataset in cBioPortal (https://www.cbioportal.org/study/clinicalData?id=stad_tcga_gdc).
From: Sex disparity in survival outcomes of advanced gastric adenocarcinoma
Males (n = 25) | Females (n = 19) | |
|---|---|---|
Median OS (Month) | 13.01 | 9.07 |
Hazardous Ratio (95% CI) | 0.62 (0.27–1.40) | |
